Supplementation with Synbiotics and/or Branched Chain Amino Acids in Hepatic Encephalopathy: A Pilot Randomised Placebo-Controlled Clinical Study

Supplementation with Synbiotics and/or Branched Chain Amino Acids in Hepatic Encephalopathy: A Pilot Randomised Placebo-Controlled Clinical Study.

Full text not available from this repository.
Item Type: Article
Status: Published
Official URL: https://doi.org/10.3390/nu11081810
Journal or Publication Title: Nutrients
Volume: 11
Number: 8
Page Range: p. 1810
Date: 2019
Divisions: Liver Injury and Cancer
Depositing User: General Admin
Identification Number: 10.3390/nu11081810
ISSN: 2072-6643
Date Deposited: 21 Dec 2020 23:07
Abstract:

Introduction: Hepatic encephalopathy (HE) is common in patients with cirrhosis and is characterised by reduced hepatic ammonia clearance. This is accompanied by alterations in gut bacteria that may be ameliorated with synbiotics (pro- and prebiotics). Branched chain amino acids (BCAAs) are thought to have a role in the detoxification of ammonia. We investigated the effects of the administration of synbiotics and/or BCAAs in treating HE.

Methods: Participants with overt HE were randomised in a blinded placebo-controlled study to receive synbiotics, BCAAs, or a combination of BCAAs and Synbiotics. Relevant biochemical and nutritional data and depression and anxiety scores (DASS-21) were collected at entry, 4 weeks, and on completion, at 8 weeks. The Trail Making Test (TMT) and Inhibitory Control Test (ICT) were used to assess cognitive function in patients withHE. Results were analysed using linear mixed effects regression analyses.

Results: Sixty-one participants were enrolled and 49 who returned for at least 1 follow-up review were included in the intention to treat analysis. The mean age was 55.8 ± 6.1 years and 86% were males. Despite evidence of a placebo effect, there was significant improvement in TMT B and ICT weighted lures in participants who received combined synbiotics/BCAAs treatment compared to placebo at study completion (p ≤ 0.05). Cognitive improvement occurred without a significant change in ammonia levels.

Conclusion: To our knowledge, this is the first study reporting that combined synbiotics and BCAAs improve HE, and that may be beneficial in the management of HE. A larger study is needed to confirm these results.

Keywords: branched chain amino acids; cognition; hepatic encephalopathy; inhibitory control test; synbiotics; trail making test.

Creators:
Creators
Email
Vidot, Helen
UNSPECIFIED
Cvejic, Erin
UNSPECIFIED
Finegan, Liam J.
UNSPECIFIED
Shores, E. Arthur
UNSPECIFIED
Bowen, David G.
UNSPECIFIED
Strasser, Simone I.
UNSPECIFIED
McCaughan, Geoffrey W.
UNSPECIFIED
Carey, Sharon
UNSPECIFIED
Allman-Farinelli, Margaret
UNSPECIFIED
Shackel, Nicholas A.
UNSPECIFIED
Last Modified: 21 Dec 2020 23:07
URI: https://eprints.centenary.org.au/id/eprint/168

Actions (login required)

View Item View Item